Literature DB >> 20358176

Botulinum toxin and urinary bladder disorders in women: new insight into an old problem.

Ervin Kocjancic, Diaa E E Rizk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20358176     DOI： 10.1007/s00192-010-1136-y

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  16 in total

1.  Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients.

Authors:  D D Dykstra; A A Sidi; A B Scott; J M Pagel; G D Goldish
Journal:  J Urol       Date:  1988-05       Impact factor: 7.450

2.  Editorial comment on: botulinum toxin A improves the quality of life of patients with neurogenic urinary incontinence.

Authors:  Ervin Kocjancic
Journal:  Eur Urol       Date:  2007-09       Impact factor: 20.096

Review 3.  Botulinum toxin in urinary incontinence.

Authors:  Jacob M Patterson; Christopher R Chapple
Journal:  Curr Opin Urol       Date:  2006-07       Impact factor: 2.309

4.  Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years.

Authors:  Manfred Stoehrer; Andreas Wolff; Guus Kramer; Rainer Steiner; Dieter Lmöchner-Ernst; Dirk Leuth; Ute Steude; Herbert Ruebben
Journal:  Urol Int       Date:  2009-12-08       Impact factor: 2.089

5.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Authors:  B Schurch; M Stöhrer; G Kramer; D M Schmid; G Gaul; D Hauri
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.

Authors:  Christopher P Smith; Piotr Radziszewski; Andrzej Borkowski; George T Somogyi; Timothy B Boone; Michael B Chancellor
Journal:  Urology       Date:  2004-11       Impact factor: 2.649

Review 7.  Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.

Authors:  Apostolos Apostolidis; Prokar Dasgupta; Pierre Denys; Sohier Elneil; Clare J Fowler; Antonella Giannantoni; Gilles Karsenty; Heinrich Schulte-Baukloh; Brigitte Schurch; Jean-Jacques Wyndaele
Journal:  Eur Urol       Date:  2008-09-17       Impact factor: 20.096

8.  Long-term safety of extended-release oxybutynin chloride in a community-dwelling population of participants with overactive bladder: a one-year study.

Authors:  Ananias Diokno; Peter Sand; Richard Labasky; Paul Sieber; Joseph Antoci; Gary Leach; Linda Atkinson; Detlef Albrecht
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity.

Authors:  André Reitz; Manfred Stöhrer; Guus Kramer; Giulio Del Popolo; Emmanuel Chartier-Kastler; Jürgen Pannek; Harald Burgdörfer; Konrad Göcking; Helmut Madersbacher; Stefan Schumacher; Rudolf Richter; Jan von Tobel; Brigitte Schurch
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

Review 10.  Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence.

Authors:  Jonathan D Campbell; Katharine S Gries; Jonathan H Watanabe; Arliene Ravelo; Roger R Dmochowski; Sean D Sullivan
Journal:  BMC Urol       Date:  2009-11-20       Impact factor: 2.264
View more
  1 in total

Review 1.  Botulinum neurotoxin type A injection of the pelvic floor muscle in pain due to spasticity: a review of the current literature.

Authors:  Alka A Bhide; Federica Puccini; Vik Khullar; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2013-01-12       Impact factor: 2.894
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.